Alunbrig (ARIAD Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Alunbrig drug offered from ARIAD Pharmaceuticals Inc.. This Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: ARIAD Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Brigatinib
SUBSTANCE NAME: BRIGATINIB
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-04-28
END MARKETING DATE: 0000-00-00


Alunbrig HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAlunbrig from ARIAD Pharmaceuticals Inc.
LABELER NAME: ARIAD Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 30(mg/1)
START MARKETING DATE: 2017-04-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76189-113_d485ee73-d30f-4a14-ae43-474317f1643e
PRODUCT NDC: 76189-113
APPLICATION NUMBER: NDA208772

Other BRIGATINIB Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ARIAD Pharmaceuticals Inc.Alunbrig